| 
February 22, 2023
Trulieve Cannabis Corp. is down to $6.55, after ending yesterday at $6.8. Overall, a 3.68% loss or 25 cents today.
United States FOMC Meeting Minutes is next today at 19:00 UTC.
Meanwhile, United States Existing Home Sales (Jan) came out at 4 million, while a consensus of analysts was expecting 4 million. United States 2-Year Note Auction released yesterday at 18:00 UTC with a figure of 4.673, while the previous figure was 4.139. United States Existing Home Sales released earlier showed a marked improvement to -0.7% from the preceding data of -2.2%, but fell short of the 2% figure forecast by a consensus of market analysts.
Trulieve Cannabis's stock value drop coincides with AbbVie is down to $150.31, losing 1.11%, after ending yesterday at $152.
Positive performances can be seen by looking at other health care stocks as Merck is trading at $110 after ending yesterday's session at $109.07 (up 0.87%). Novartis added 0.7% to its value, now trading at $87.37.
With markets struggling for positive sentiment, upcoming macro data could potentially attract buyers in the market as tomorrow at 16:00 UTC data for United States Crude Oil Inventories will be released, with an expected decline to 1.17 million from the preceding figure of 16.28 million. United States Initial Jobless Claims projected to come out at 200,000 — worse than previous data of 194,000; data will be released tomorrow at 13:30 UTC.
Furthermore, United States GDP figure is projected at 2.9. It previously stood at 2.9; data will be released tomorrow at 13:30 UTC.
The leading CBD products developer is now trading 43.8% below its 3-month high of $22.54.
